J63.1 ICD-10-CM Code: Bauxite fibrosis (of lung)
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the respiratory system (J00-J99) / Lung diseases due to external agents (J60-J70)
J63.1
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceBauxite fibrosis (of lung)
A lung disease caused by inhaling bauxite dust, leading to scarring and inflammation of lung tissue. This occupational condition typically affects workers in aluminum mining and processing.

Buddy Insight
Bauxite fibrosis is an occupational pneumoconiosis that carries significant risk adjustment weight because it represents irreversible lung parenchymal damage requiring ongoing monitoring and treatment.
CMS-HCC V28
MappedHCC 280
RAF 0.319
CMS-HCC V24
MappedHCC 112
RAF 0.219
ACA/HHS
MappedHCC 162
Varies by metal level
ESRD/PACE
MappedHCC 112
RAF 0.058
RXHCC
N/A—
Not mapped
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for J63.1 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for J63.1 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for J63.1 in this effective period.
Excludes 1
Official- pneumoconiosis with tuberculosis, any type in A15 (J65)
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for J63.1 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for J63.1 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for J63.1 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is J63.1 an HCC code?
Yes. J63.1 (Bauxite fibrosis (of lung)) maps to Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders under the CMS-HCC V28 risk adjustment model (and Fibrosis of Lung and Other Chronic Lung Disorders under V24), with a community non-dual aged RAF of 0.319. It is billable for payment year 2026.
Coder answer: J63.1 is billable and maps to V28 HCC 280, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- J63.1
- Description
- Bauxite fibrosis (of lung)
- HCC (V28)
- HCC 280 — Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders
- RAF
- 0.319
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work J63.1 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for J63.1
For J63.1 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed J63.1 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
J63.1 is the ICD-10-CM diagnosis code for bauxite fibrosis (of lung). A lung disease caused by inhaling bauxite dust, leading to scarring and inflammation of lung tissue. This occupational condition typically affects workers in aluminum mining and processing. J63.1 sits in the ICD-10-CM chapter for diseases of the respiratory system (j00-j99), within the section covering lung diseases due to external agents (j60-j70).
Under the CMS-HCC V28 risk adjustment model, J63.1 maps to Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders (HCC 280) with a community, non-dual, aged base RAF weight of 0.319. Under the older CMS-HCC V24 model, J63.1 maps to Fibrosis of Lung and Other Chronic Lung Disorders (HCC 112) with a community, non-dual, aged base RAF weight of 0.219. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Verify occupational exposure history to bauxite dust in patient documentation. Because J63.1 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for J63.1 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Verify occupational exposure history to bauxite dust in patient documentation
- •Ensure this is not being confused with other pneumoconiosis types; bauxite fibrosis is specifically related to aluminum ore processing
Clinical Significance
Bauxite fibrosis is an occupational pneumoconiosis that carries significant risk adjustment weight because it represents irreversible lung parenchymal damage requiring ongoing monitoring and treatment. This condition indicates chronic respiratory impairment from aluminum dust exposure, increasing the patient's expected healthcare utilization for pulmonary function testing, imaging, and potentially oxygen therapy.
Documentation Requirements
- ✓Documented occupational history with specific exposure to bauxite (aluminum ore) dust
- ✓Imaging findings (chest X-ray or CT) showing fibrotic changes consistent with pneumoconiosis
- ✓Pulmonary function test results demonstrating restrictive pattern
- ✓Duration and intensity of exposure
- ✓Current symptom burden (dyspnea, cough, exercise intolerance)
- ✓Treatment plan including any oxygen requirements or medications
Commonly Confused Codes
- •J63.0 (Aluminosis of lung): aluminosis is from aluminum dust generally, while J63.1 is specifically from bauxite ore dust
- •J63.6 (Pneumoconiosis due to other specified inorganic dusts): use J63.1 when bauxite is specifically identified
- •J84.10 (Pulmonary fibrosis, unspecified): use J63.1 when fibrosis has a documented occupational bauxite cause
- •J64 (Unspecified pneumoconiosis): always code to the specific dust type when known

